1. [SCIE] Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial [HEPATOLOGY] - 2023-05-01 2. [SCIE] Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma [Therapeutic advances in Medical Oncology] - 2022-05-09 3. [SCIE] Blockade of GRP78 Translocation to the Cell Surface by HDAC6 Inhibition Suppresses Proliferation of Cholangiocarcinoma Cells [ANTICANCER RESEARCH] - 2022-01-01 4. [SCIE] Evaluating waiting time with real-world health information in a high-volume cancer center [MEDICINE] - 2020-09-01 5. [SCIE] Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis [THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY] - 2020-05-27
교수/연구
